Solasia Pharma KK

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3436500007
JPY
30.00
1 (3.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Poor long term growth as Operating profit has grown by an annual rate -1.61% of over the last 5 years

 
3

With a growth in Net Sales of 43.83%, the company declared Outstanding results in Dec 25

4

Risky - Negative EBITDA

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 8,097 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.00

stock-summary
Return on Equity

-100.00%

stock-summary
Price to Book

4.51

Revenue and Profits:
Net Sales:
338 Million
(Quarterly Results - Dec 2025)
Net Profit:
-150 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.14%
0%
7.14%
6 Months
-18.92%
0%
-18.92%
1 Year
-23.08%
0%
-23.08%
2 Years
-11.76%
0%
-11.76%
3 Years
-38.78%
0%
-38.78%
4 Years
-63.86%
0%
-63.86%
5 Years
-80.26%
0%
-80.26%

Solasia Pharma KK for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-25.19%
EBIT Growth (5y)
-1.61%
EBIT to Interest (avg)
-229.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.23
Sales to Capital Employed (avg)
0.29
Tax Ratio
0.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.92
EV to EBIT
-2.95
EV to EBITDA
-3.13
EV to Capital Employed
-29.66
EV to Sales
17.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-224.80%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 43.83% vs 1,466.67% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 85.98% vs -211.05% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "338.00",
          "val2": "235.00",
          "chgp": "43.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-138.00",
          "val2": "-1,024.00",
          "chgp": "86.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-150.00",
          "val2": "-1,070.00",
          "chgp": "85.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-434.90%",
          "val2": "-4,502.10%",
          "chgp": "406.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 35.76% vs -48.78% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 54.87% vs -74.55% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "429.00",
          "val2": "316.00",
          "chgp": "35.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-822.00",
          "val2": "-796.00",
          "chgp": "-3.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.00",
          "val2": "5.00",
          "chgp": "180.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-959.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-876.00",
          "val2": "-1,941.00",
          "chgp": "54.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,002.30%",
          "val2": "-3,136.10%",
          "chgp": "113.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
338.00
235.00
43.83%
Operating Profit (PBDIT) excl Other Income
-138.00
-1,024.00
86.52%
Interest
1.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-150.00
-1,070.00
85.98%
Operating Profit Margin (Excl OI)
-434.90%
-4,502.10%
406.72%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 43.83% vs 1,466.67% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 85.98% vs -211.05% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
429.00
316.00
35.76%
Operating Profit (PBDIT) excl Other Income
-822.00
-796.00
-3.27%
Interest
14.00
5.00
180.00%
Exceptional Items
0.00
-959.00
100.00%
Consolidate Net Profit
-876.00
-1,941.00
54.87%
Operating Profit Margin (Excl OI)
-2,002.30%
-3,136.10%
113.38%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 35.76% vs -48.78% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 54.87% vs -74.55% in Dec 2024

stock-summaryCompany CV
About Solasia Pharma KK stock-summary
stock-summary
Solasia Pharma KK
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available